KAS
IRON icon

Kemnay Advisory Services’s Disc Medicine IRON Stock Holding History

Kemnay Advisory Services’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.7K Buy
269
+23
+9% +$1.58K ﹤0.01% 752
2026
Q1 		$15.7K Buy
246
+177
+257% +$12.3K ﹤0.01% 821
2025
Q4 		$5.48K Buy
+69
New +$5.83K ﹤0.01% 841

Other funds holding IRON

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Kemnay Advisory Services's IRON Position: Q2 2026 in Review

Kemnay Advisory Services increased its Disc Medicine (IRON) stake by 9.3% in Q2 2026, buying an estimated $1.58K and bringing the position to 269 shares worth $19.7K. The position accounts for ﹤0.01% of the portfolio, ranked #752.

Kemnay Advisory Services first reported a position in IRON in Q4 2025 and has held it in 3 quarters since. 216 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

  • Kemnay Advisory Services held 269 shares of Disc Medicine worth $19.7K as of Q2 2026.
  • Kemnay Advisory Services bought 23 Disc Medicine shares in Q2 2026, an estimated $1.58K.
  • Disc Medicine made up ﹤0.01% of Kemnay Advisory Services's portfolio in Q2 2026, its #752 holding.
  • Kemnay Advisory Services first reported a position in Disc Medicine in Q4 2025 and has held it in 3 quarters since.
  • 216 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on Kemnay Advisory Services's 13F filing for Q2 2026, filed 14 Aug 2026.